Coldstream Capital Management Inc. Has $4.44 Million Stock Holdings in Stryker Corporation $SYK

Coldstream Capital Management Inc. grew its stake in shares of Stryker Corporation (NYSE:SYK) by 23.0% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,007 shares of the medical technology company’s stock after purchasing an additional 2,248 shares during the quarter. Coldstream Capital Management Inc.’s holdings in Stryker were worth $4,440,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Davis R M Inc. grew its holdings in Stryker by 1.8% during the third quarter. Davis R M Inc. now owns 138,732 shares of the medical technology company’s stock worth $51,285,000 after purchasing an additional 2,512 shares during the period. Terra Alpha Investments LLC bought a new stake in Stryker in the third quarter valued at approximately $1,216,000. Kepler Cheuvreux Suisse SA acquired a new stake in shares of Stryker in the third quarter valued at approximately $27,952,000. Diversified Trust Co boosted its stake in shares of Stryker by 45.6% during the 3rd quarter. Diversified Trust Co now owns 12,445 shares of the medical technology company’s stock worth $4,601,000 after acquiring an additional 3,899 shares during the period. Finally, SVB Wealth LLC bought a new position in shares of Stryker during the 2nd quarter worth approximately $4,785,000. Institutional investors own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Raymond James Financial upgraded Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price target on the stock in a research note on Tuesday, January 6th. William Blair reiterated an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. Truist Financial dropped their price objective on shares of Stryker from $400.00 to $392.00 and set a “hold” rating on the stock in a research report on Thursday, December 18th. Citizens Jmp upgraded shares of Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 target price for the company in a research note on Friday, December 19th. Finally, BTIG Research lifted their target price on shares of Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Fourteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and a consensus price target of $427.50.

Stryker Trading Down 1.0%

Shares of Stryker stock opened at $345.64 on Thursday. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. Stryker Corporation has a 12-month low of $328.23 and a 12-month high of $404.87. The company has a market capitalization of $132.27 billion, a price-to-earnings ratio of 41.15, a PEG ratio of 2.04 and a beta of 0.85. The firm’s 50-day moving average price is $364.43 and its two-hundred day moving average price is $366.61.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. The company had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.01 EPS. On average, analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is currently 41.90%.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of Stryker stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the transaction, the director owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. This trade represents a 9.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 5.90% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.